Quality ID #1 (NQF 0059): Diabetes: Hemoglobin A1c (HbA1c ...

Measure #324: Cardiac Stress Imaging Not Meeting ...

2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging Indication 12: Detection of CAD/Risk Assessment Without Ischemic Equivalent: Asymptomatic: Low CHD risk (ATP III risk criteria) - Inappropriate (1) 2006 Appropriateness Criteria for CCT and CMR Indication 10 - Detection of CAD: Asymptomatic (Use of CCTA)

  Criteria, Appropriate, Appropriate use criteria for

Quality ID #323: Cardiac Stress Imaging Not Meeting ...

#323: Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI) Please refer to the specific section of the Measure Specification to identify the denominator and numerator

  Criteria, Appropriate, Appropriate use criteria

Quality ID #46 (NQF 0097): Medication Reconciliation Post ...

Medication reconciliation post-discharge is an important step to catch potentially harmful omissions or changes in prescribed medications, particularly in elderly patients that are prescribed a greater quantity and variety of medications (Leape, 1991). Although the magnitude of the effect of medication reconciliation alone on patient

  Discharge, Post, Post discharge

Quality ID #154 (NQF: 0101): Falls: Risk Assessment

Foundation (PCPI®) and the National Committee for Quality Assurance (NCQA). These Measures are not a clinical guideline and does not establish a standard of medical care, and has not been tested for all potential applications. The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial

  Fall, Assessment, Quality, Risks, Assurance, 1010, Risk assessment, Quality assurance

Quality ID #134 (NQF 0418): Preventive Care and Screening ...

Quality ID #134 (NQF 0418): Preventive Care and Screening: Screening for Depression and Follow-Up ... (6.6 percent) adults aged 18 or older had at least one MDE in the past year, with 10.2 million adults (4.3 percent) having one MDE with severe . impairment in the past year (Center for Behavioral Health Statistics and Quality, 2015). Data ...

  Screening, Care, Preventive, Depression, 1048, Screening for depression, Nqf 0418, Preventive care and screening

Quality ID #134: Preventive Care and Screening: Screening ...

Dementia (CSDD), PRIME MD-PHQ-2, Hamilton Rating Scale for Depression (HAM-D), Quick Inventory of Depressive Symptomatology Self-Report (QID-SR), Computerized Adaptive Testing Depression Inventory (CAT-DI), and Computerized Adaptive Diagnostic Screener (CAD-MDD) • Perinatal Screening Tools

  Screening, Care, Preventive, Dementia, Preventive care and screening

Quality ID #154 (NQF: 0101): Falls: Risk Assessment ...

Quality ID #154 (NQF: 0101): Falls: Risk Assessment – National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE TYPE: Process This is a two-part measure which is paired with Measure #155: Falls: Plan of Care. If the falls risk assessment

  Quality, Strategy, Quality strategy

Quality ID #130 (NQF 0419): Documentation of Current ...

*Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). These non-covered services should be counted in the denominator population for MIPS CQMs. Denominator Criteria (Eligible Cases): Patients aged ≥ 18 years on date of encounter . AND

  Code

#407: Appropriate Treatment of MSSA Bacteremia

the measure based on the services provided and the measure-specific denominator coding. Measure Reporting: The listed denominator criteria is used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions allowed by the measure. The quality-data codes listed do not ...

  Quality, Measure

Quality ID #236: Controlling High Blood Pressure

Quality ID #236: Controlling High Blood Pressure – National Quality Strategy Domain: Effective Clinical Care – Meaningful Measure Area: Management of Chronic Conditions. 2021 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Intermediate Outcome – High Priority . DESCRIPTION:

  High, Quality

BUREAU FOR MEDICAL SERVICES EFFECTIVE WEST VIRGINIA ...

galantamine galantamine ER RAZADYNE ER (galantamine) rivastigmine *Donepezil 23 mg tablets will be authorized if the following criteria are met: 1. There is a diagnosis of moderate-to-severe Alzheimer’s Disease and 2. There has been a trial of donepezil 10 mg daily for at least three (3) months and donepezil 20 mg daily for

  Galantamine, Galantamine galantamine

2021 EMPIRE PLAN FLEXIBLE FORMULARY DRUG LIST

Dec 15, 2020 · galantamine galantamine ext-rel memantine (generic NAMENDA) rivastigmine rivastigmine transdermal (generic EXELON PATCH) NAMZARIC § MONOAMINE OXIDASE INHIBITORS (MAOIs) phenelzine tranylcypromine MARPLAN § SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) citalopram escitalopram fluoxetine (except fluoxetine tablet …

  Galantamine, Galantamine galantamine

January 2022 2022 EMPIRE PLAN FLEXIBLE FORMULARY …

galantamine galantamine ext-rel memantine (generic NAMENDA) rivastigmine rivastigmine transdermal (generic EXELON PATCH) NAMZARIC ANTIDEPRESSANTS § MONOAMINE OXIDASE INHIBITORS (MAOIs) phenelzine tranylcypromine § SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs) citalopram escitalopram fluoxetine (except fluoxetine tablet 60

  Plan, Empires, Galantamine, Empire plan, Galantamine galantamine

The Assessment of Cardiac Status Before Prescribing Acetyl ...

The AChEIs are donepezil, rivastigmine and galantamine. NICE recommends these drugs for use for people who have mild to moderate Alzheimer’s Disease (NICE, 2011). NICE guidelines also recommend that an AChEI is offered to a person who has dementia with Lewy bodies or Parkinson's disease dementia if they also have

  Galantamine

Suggestions For Drug Monitoring in Adults in Primary Care

Galantamine is contraindicated in people with severe renal impairment (creatinine clearance less than 9mL/min or chronic kidney disease stage 5 [estimated glomerular filtration rate < 5mL/minute/1.73m2]) or severe hepatic impairment (Child –Pugh score greater than 9)2

  Galantamine

Louisiana Medicaid Preferred Drug List (PDL)/Non-Preferred ...

Jan 01, 2022 · Louisiana Medicaid Preferred Drug List (PDL)/Non-Preferred Drug List (NPDL) • The PDL applies to all individuals enrolled in Louisiana Medicaid, including those covered by one of the managed care organizations (MCOs) and those in the Fee-for-Service (FFS) program

PowerPoint Presentation - ALZHEIMER’S DISEASE

Prevalence and alence and Impact of ADImpact of AD AAD is tD is the mosstt c coommon c cause ofause of demeentntia in people 65 yearars ans and older

Pennsylvania Department of Human Services Statewide ...

May 21, 2001 · Pennsylvania Department of Human Services Statewide Preferred Drug List (PDL)* *The Statewide PDL is not an all-inclusive list of drugs covered by Medical Assistance.Drugs in Statewide PDL classes that are new to market will be non-preferred until reviewed by the DHS Pharmacy and Therapeutics Committee.